Influenza A (H1N1) Q & A（新型インフルエンザQ＆A・英語版）

http://www.fukushihoken.metro.tokyo.jp/iryo/kansen/sinpojiumu/SwineInfluenzafaq/index.html


Q　 What are the human symptoms of Influenza A(H1N1)?
A　 Symptoms such as fever, lethargy, loss of appetite, and
coughing are seen. There are also patients who complain
of symptoms including a runny nose, sore throat, nausea,
vomiting, and diarrhea.




Q　How does Influenza A(H1N1) spread?
A　The virus is transmitted from person to person, through
contact with saliva droplets (coughing or sneezing) or with
contaminated surfaces and materials, including hands, toys,
plates, glasses, computer keyboards, telephones, door handles,
bathroom faucets and other daily living utensils.




Q　What protective steps should I take?
A　There have been no confirmed cases of people infected
with Influenza A(H1N1) in Japan (as of April 30).
If you plan to go to the United States or Mexico,
you are advised to:
1) Wear a mask to prevent infections through coughs or sneezes
2) Wash your hands often
3) Consult a local doctor if flu-like symptoms appear such as fever
and cough
In addition, those who had flu-like symptoms during their stay abroad
or have such symptoms upon their return, are requested to report
this to the quarantine office.




Q　 I don’t have any symptoms, but is there a place where I can be tested
for this?
A　 You do not need to be tested if you do not have any symptoms.
Please note that there are no tests that can confirm infection
before the symptoms appear even for those with the high
possibility of being infected due to their travel abroad.
Please consult the public health center if any symptoms
appear within 10 days of your return. If you have had
close contact with an infected person, please also call
the public health center.
http://www.metro.tokyo.jp/INET/OSHIRASE/2009/04/20j4u501.htm




Q Is there a vaccine for Influenza A (H1N1)?
A　There is currently no effective vaccine to protect
humans from Influenza A(H1N1). It is also believed
that seasonal influenza vaccines are not effective
against this virus. However scientific work is now
underway on the development of a vaccine with the
aim to have it available within the year.